These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27584691)

  • 1. Whole-Genome Characterization and Strain Comparison of VT2f-Producing Escherichia coli Causing Hemolytic Uremic Syndrome.
    Grande L; Michelacci V; Bondì R; Gigliucci F; Franz E; Badouei MA; Schlager S; Minelli F; Tozzoli R; Caprioli A; Morabito S
    Emerg Infect Dis; 2016 Dec; 22(12):2078-2086. PubMed ID: 27584691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Genome-Based Public Health Surveillance of Less Common Shiga Toxin-Producing Escherichia coli Serovars and Untypeable Strains Identifies Four Novel O Genotypes.
    Lang C; Hiller M; Konrad R; Fruth A; Flieger A
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31366691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.
    Bielaszewska M; Mellmann A; Zhang W; Köck R; Fruth A; Bauwens A; Peters G; Karch H
    Lancet Infect Dis; 2011 Sep; 11(9):671-6. PubMed ID: 21703928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing
    Hua Y; Chromek M; Frykman A; Jernberg C; Georgieva V; Hansson S; Zhang J; Marits AK; Wan C; Matussek A; Bai X
    Virulence; 2021 Dec; 12(1):1296-1305. PubMed ID: 33939581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
    Ibarra C; Amaral MM; Palermo MS
    IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany.
    Rasko DA; Webster DR; Sahl JW; Bashir A; Boisen N; Scheutz F; Paxinos EE; Sebra R; Chin CS; Iliopoulos D; Klammer A; Peluso P; Lee L; Kislyuk AO; Bullard J; Kasarskis A; Wang S; Eid J; Rank D; Redman JC; Steyert SR; Frimodt-Møller J; Struve C; Petersen AM; Krogfelt KA; Nataro JP; Schadt EE; Waldor MK
    N Engl J Med; 2011 Aug; 365(8):709-17. PubMed ID: 21793740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary Context of Non-Sorbitol-Fermenting Shiga Toxin-Producing Escherichia coli O55:H7.
    Schutz K; Cowley LA; Shaaban S; Carroll A; McNamara E; Gally DL; Godbole G; Jenkins C; Dallman TJ
    Emerg Infect Dis; 2017 Dec; 23(12):1966-1973. PubMed ID: 29148397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the genomic relatedness and evolutionary rates of persistent verotoxigenic
    Wang LYR; Jokinen CC; Laing CR; Johnson RP; Ziebell K; Gannon VPJ
    Microb Genom; 2020 Jun; 6(6):. PubMed ID: 32496181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
    Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway.
    Haugum K; Johansen J; Gabrielsen C; Brandal LT; Bergh K; Ussery DW; Drabløs F; Afset JE
    PLoS One; 2014; 9(10):e111788. PubMed ID: 25360710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hemolytic-uremic syndrome-associated strain O113:H21 Shiga toxin-producing Escherichia coli specifically expresses a transcriptional module containing dicA and is related to gene network dysregulation in Caco-2 cells.
    Bando SY; Iamashita P; Guth BE; Dos Santos LF; Fujita A; Abe CM; Ferreira LR; Moreira-Filho CA
    PLoS One; 2017; 12(12):e0189613. PubMed ID: 29253906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving hazard characterization in microbial risk assessment using next generation sequencing data and machine learning: Predicting clinical outcomes in shigatoxigenic Escherichia coli.
    Njage PMK; Leekitcharoenphon P; Hald T
    Int J Food Microbiol; 2019 Mar; 292():72-82. PubMed ID: 30579059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic uremic syndrome in a 65-Year-old male linked to a very unusual type of stx2e- and eae-harboring O51:H49 shiga toxin-producing Escherichia coli.
    Fasel D; Mellmann A; Cernela N; Hächler H; Fruth A; Khanna N; Egli A; Beckmann C; Hirsch HH; Goldenberger D; Stephan R
    J Clin Microbiol; 2014 Apr; 52(4):1301-3. PubMed ID: 24501025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomics of recent Shiga toxin-producing Escherichia coli O104:H4: short-term evolution of an emerging pathogen.
    Grad YH; Godfrey P; Cerquiera GC; Mariani-Kurkdjian P; Gouali M; Bingen E; Shea TP; Haas BJ; Griggs A; Young S; Zeng Q; Lipsitch M; Waldor MK; Weill FX; Wortman JR; Hanage WP
    mBio; 2013 Jan; 4(1):e00452-12. PubMed ID: 23341549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved Stx2 phages from Escherichia coli O103:H25 isolated from patients suffering from hemolytic uremic syndrome.
    Sekse C; Muniesa M; Wasteson Y
    Foodborne Pathog Dis; 2008 Dec; 5(6):801-10. PubMed ID: 19014273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Serological Tests Against Verotoxigenic Escherichia coli in Hemolytic Uremic Syndrome in Children.
    Leszczyńska B; Ziółkowska H; Podsiadły E; Szych J; Rastawicki W; Demkow U; Roszkowska-Blaim M
    Adv Clin Exp Med; 2015; 24(6):1031-6. PubMed ID: 26771976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Shiga-toxigenic Escherichia coli isolated from cases of diarrhoea & haemolytic uremic syndrome in north India.
    Kumar A; Taneja N; Bharti B; Sharma M
    Indian J Med Res; 2014 Dec; 140(6):778-84. PubMed ID: 25758577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHARACTERISTICS OF DIARRHEAL DISEASE COMPLICATED WITH HEMOLYTIC UREMIC SYNDROME AMONG CHILDREN IN GEORGIA, 2009-2016.
    Chokoshvili O; Vepkhvadze N; Davitaia T; Tevzadze L; Tsertsvadze T
    Georgian Med News; 2018 Oct; (283):123-129. PubMed ID: 30516507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization and phylogeny of Shiga toxin-producing Escherichia coli isolates obtained from two Dutch regions using whole genome sequencing.
    Ferdous M; Friedrich AW; Grundmann H; de Boer RF; Croughs PD; Islam MA; Kluytmans-van den Bergh MF; Kooistra-Smid AM; Rossen JW
    Clin Microbiol Infect; 2016 Jul; 22(7):642.e1-9. PubMed ID: 27058887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.